Neumora Therapeutics
Quarterly Financials
| Values in thousands | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 |
|---|---|---|---|---|
Revenue | $0 | $0 | $0 | $0 |
EBITDA | -54,040 | -70,936 | -62,765 | -76,490 |
EBIT | -71,093 | -62,922 | -76,646 | |
Net Income | -52,731 | -67,992 | -58,819 | -72,547 |
Net Change In Cash | 0 | 0 | 0 | 0 |
Free Cash Flow | -52,404 | -59,448 | -50,340 | -32,708 |
Cash | 124,523 | 126,860 | 142,148 | 275,714 |
Basic Shares | 161,691 | 161,451 | 160,984 | 159,576 |
Annual Financials
| Values in thousands | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
Revenue | $0 | $0 | $0 | $0 |
Gross Profit | -668 | -2,697 | -1,551 | |
EBITDA | -242,978 | -187,526 | -135,276 | -236,785 |
EBIT | -243,609 | -188,194 | -137,973 | -238,336 |
Net Income | -243,787 | -235,925 | -130,904 | -237,312 |
Net Change In Cash | 0 | 0 | 0 | 0 |
Free Cash Flow | -182,936 | -163,395 | -115,407 | -76,237 |
Cash | 142,148 | 374,038 | 240,943 | 409,247 |
Basic Shares | 159,377 | 158,832 | 151,949 | 151,949 |
Earnings Calls
| Quarter | EPS |
|---|---|
2025-09-30 | $0 |
2025-06-30 | -$0.33 |
2025-03-31 | -$0.42 |
2024-12-31 | -$0.37 |
